UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Metabolic dysfunction-associated fatty liver disease increases risk of adverse outcomes in patients with chronic hepatitis B

JHEP reports, 2021-10, Vol.3 (5), p.100350, Article 100350

2021

Volltextzugriff (PDF)

Development of a novel non-invasive biomarker panel for hepatic fibrosis in MASLD

Nature communications, 2024-05, Vol.15 (1), p.4564-14, Article 4564

2024

Volltextzugriff (PDF)

Unique intrahepatic transcriptomics profiles discriminate the clinical phases of a chronic HBV infection

PloS one, 2017-06, Vol.12 (6), p.e0179920

2017

Volltextzugriff (PDF)

End-of-treatment HBsAg, HBcrAg and HBV RNA predict the risk of off-treatment ALT flares in chronic hepatitis B patients

Journal of microbiology, immunology and infection, 2023-02, Vol.56 (1), p.31-39

2023

Volltextzugriff (PDF)

Improved Survival beyond 28 Days up to 1 Year after CytoSorb Treatment for Refractory Septic Shock: A Propensity-Weighted Retrospective Survival Analysis

Blood purification, 2021, Vol.50 (4-5), p.539-545

2021

Volltextzugriff (PDF)

Nonalcoholic Steatohepatitis Is Associated With Liver‐Related Outcomes and All‐Cause Mortality in Chronic Hepatitis B

Hepatology (Baltimore, Md.), 2020-02, Vol.71 (2), p.539-548

2020

Volltextzugriff (PDF)

The membrane‐bound O‐acyltransferase domain‐containing 7 variant rs641738 increases inflammation and fibrosis in chronic hepatitis B

Hepatology (Baltimore, Md.), 2017-06, Vol.65 (6), p.1840-1850

2017

Volltextzugriff (PDF)

Plasma proteomic signature of fatty liver disease: The Rotterdam Study

Hepatology (Baltimore, Md.), 2023-07, Vol.78 (1), p.284-294

2023

Volltextzugriff (PDF)

Hepatitis B Surface Antigen Levels Can Be Used to Rule Out Cirrhosis in Hepatitis B e Antigen-Positive Chronic Hepatitis B: Results From the SONIC-B Study

The Journal of infectious diseases, 2022-06, Vol.225 (11), p.1967-1973

2022

Volltextzugriff (PDF)

Repeated Measurements of Hepatitis B Surface Antigen Identify Carriers of Inactive HBV During Long-term Follow-up

Clinical gastroenterology and hepatology, 2016-10, Vol.14 (10), p.1481-1489.e5

2016

Volltextzugriff (PDF)

Very low probability of significant liver inflammation in chronic hepatitis B patients with low ALT levels in the absence of liver fibrosis

Alimentary pharmacology & therapeutics, 2020-10, Vol.52 (8), p.1399-1406

2020

Volltextzugriff (PDF)

Association Between the Presence of Metabolic Comorbidities and Liver-Related Events in Patients With Chronic Hepatitis B

Clinical gastroenterology and hepatology, 2023-11, Vol.21 (12), p.3089-3096.e1

2023

Volltextzugriff (PDF)

Lifetime prevalence and associated factors of itch with skin conditions: atopic dermatitis, psoriasis and dry skin in individuals aged > 50 years

Clinical and experimental dermatology, 2024-08, Vol.49 (9), p.1036-1043

2024

Volltextzugriff (PDF)

Letter: rates and determinants of significant liver inflammation in chronic hepatitis B virus‐infected patients with low ALT levels in the absence of significant fibrosis—authors' reply

Alimentary pharmacology & therapeutics, 2021-01, Vol.53 (1), p.215-216

2021

Volltextzugriff (PDF)

Genome-wide Association Study Identifies Genetic Variants Associated With Early and Sustained Response to (Pegylated) Interferon in Chronic Hepatitis B Patients: The GIANT-B Study

Clinical infectious diseases, 2019-11, Vol.69 (11), p.1969-1979

2019

Volltextzugriff (PDF)

Effects of on‐treatment ALT flares on serum HBsAg and HBV RNA in patients with chronic HBV infection

Journal of viral hepatitis, 2021-12, Vol.28 (12), p.1729-1737

2021

Volltextzugriff (PDF)

CD4+ CXCR5+ T cells in chronic HCV infection produce less IL-21, yet are efficient at supporting B cell responses

Journal of hepatology, 2015-02, Vol.62 (2), p.303-310

2015

Volltextzugriff (PDF)

Optimisation of the use of APRI and FIB-4 to rule out cirrhosis in patients with chronic hepatitis B: results from the SONIC-B study

The lancet. Gastroenterology & hepatology, 2019-07, Vol.4 (7), p.538-544

2019

Volltextzugriff (PDF)

COVID‐19 in gastroenterology: Where are we now? Current evidence on the impact of COVID‐19 in gastroenterology

United European gastroenterology journal, 2021-09, Vol.9 (7), p.750-765

2021

Volltextzugriff (PDF)

Machine-learning based patient classification using Hepatitis B virus full-length genome quasispecies from Asian and European cohorts

Scientific reports, 2019-12, Vol.9 (1), p.18892-12, Article 18892

2019

Volltextzugriff (PDF)

Dual proteotoxic stress accelerates liver injury via activation of p62‐Nrf2

The Journal of pathology, 2021-05, Vol.254 (1), p.80-91, Article path.5643

2021

Volltextzugriff (PDF)

Tenofovir alafenamide for hepatitis B: evolution or revolution?

The lancet. Gastroenterology & hepatology, 2016-11, Vol.1 (3), p.174-175

Brouwer, Willem P

2016

Volltextzugriff (PDF)

Posttreatment Hepatitis B Surface Antigen Seroreversion: The Bane of Combination Therapy in Chronic Hepatitis B?

Gastroenterology (New York, N.Y. 1943), 2016-05, Vol.150 (5), p.1254-1255

2016

Volltextzugriff (PDF)

Studies of IL28B genotype and response to peginterferon in chronic hepatitis B should be stratified by HBV genotype

Hepatology (Baltimore, Md.), 2013-03, Vol.57 (3), p.1283-1283

2013

Volltextzugriff (PDF)

The impact of PNPLA3 (rs738409 C>G) polymorphisms on liver histology and long-term clinical outcome in chronic hepatitis B patients

Liver international, 2015-02, Vol.35 (2), p.438-447

2015

Volltextzugriff (PDF)

1 – 25 von 141

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(136)
Mit Volltextzugriff
(118)

Publikationsform

Sprache

Englisch
(140)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Hepatology
(11)
Stroke
(6)
American Journal Of Human Genetics
(5)
Blood
(4)
Clinical Gastroenterology And Hepatology
(4)
Colorectal Disease
(4)
Plos One
(4)
Archives Of Neurology
(3)
Jama Neurology
(3)
Journal Of Hepatology
(3)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Metabolic dysfunction-associated fatty liver disease increases risk of adverse outcomes in patients with chronic hepatitis B

Development of a novel non-invasive biomarker panel for hepatic fibrosis in MASLD

Unique intrahepatic transcriptomics profiles discriminate the clinical phases of a chronic HBV infection

End-of-treatment HBsAg, HBcrAg and HBV RNA predict the risk of off-treatment ALT flares in chronic hepatitis B patients

Improved Survival beyond 28 Days up to 1 Year after CytoSorb Treatment for Refractory Septic Shock: A Propensity-Weighted Retrospective Survival Analysis

Nonalcoholic Steatohepatitis Is Associated With Liver‐Related Outcomes and All‐Cause Mortality in Chronic Hepatitis B

The membrane‐bound O‐acyltransferase domain‐containing 7 variant rs641738 increases inflammation and fibrosis in chronic hepatitis B

Plasma proteomic signature of fatty liver disease: The Rotterdam Study

Hepatitis B Surface Antigen Levels Can Be Used to Rule Out Cirrhosis in Hepatitis B e Antigen-Positive Chronic Hepatitis B: Results From the SONIC-B Study

Repeated Measurements of Hepatitis B Surface Antigen Identify Carriers of Inactive HBV During Long-term Follow-up

Very low probability of significant liver inflammation in chronic hepatitis B patients with low ALT levels in the absence of liver fibrosis

Association Between the Presence of Metabolic Comorbidities and Liver-Related Events in Patients With Chronic Hepatitis B

Lifetime prevalence and associated factors of itch with skin conditions: atopic dermatitis, psoriasis and dry skin in individuals aged > 50 years

Letter: rates and determinants of significant liver inflammation in chronic hepatitis B virus‐infected patients with low ALT levels in the absence of significant fibrosis—authors' reply

Genome-wide Association Study Identifies Genetic Variants Associated With Early and Sustained Response to (Pegylated) Interferon in Chronic Hepatitis B Patients: The GIANT-B Study

Effects of on‐treatment ALT flares on serum HBsAg and HBV RNA in patients with chronic HBV infection

CD4+ CXCR5+ T cells in chronic HCV infection produce less IL-21, yet are efficient at supporting B cell responses

Optimisation of the use of APRI and FIB-4 to rule out cirrhosis in patients with chronic hepatitis B: results from the SONIC-B study

COVID‐19 in gastroenterology: Where are we now? Current evidence on the impact of COVID‐19 in gastroenterology

Machine-learning based patient classification using Hepatitis B virus full-length genome quasispecies from Asian and European cohorts

Dual proteotoxic stress accelerates liver injury via activation of p62‐Nrf2

Tenofovir alafenamide for hepatitis B: evolution or revolution?

Posttreatment Hepatitis B Surface Antigen Seroreversion: The Bane of Combination Therapy in Chronic Hepatitis B?

Studies of IL28B genotype and response to peginterferon in chronic hepatitis B should be stratified by HBV genotype

The impact of PNPLA3 (rs738409 C>G) polymorphisms on liver histology and long-term clinical outcome in chronic hepatitis B patients

Suchergebnisse filtern